Etrasimod,
1206123-37-6,
APD334,
APD-334,
UNII-6WH8495MMH,
6WH8495MMH,
CHEMBL3358920,
Etrasimod (USAN),
Etrasimod [USAN],
Etrasimod(APD334),
GTPL9331,
SCHEMBL1919311,
MVGWUTBTXDYMND-QGZVFWFLSA-N,
BCP19558,
EX-A1633,
KS-00001D0Q,
BDBM50041691,
AKOS032944972,
ZINC117522788,
APD334-003,
compound 4 [PMID: 25516790],
CS-6181,
SB17088,
HY-12789,
D10930,
F10118,
(R)-2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid,
(R)-2-(7-(4-Cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl) acetic acid,
(R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid,
2-[(3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid,